Elfring, G: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Sensory outcomes of the anterior tongue after lingual nerve repair in oropharyngeal cancer

T. T. ELFRING, C. A. BOLIEK, H. SEIKALY, J. HARRIS, J. M. RIEGER

Journal:

Journal of Oral Rehabilitation

Year:

2012

Language:

english

File:

PDF, 217 KB

english, 2012

52

NEW EVIDENCE ON THE EXPANSION OF SERVICE EMPLOYMENT IN ADVANCED ECONOMIES

Journal:

Review of Income and Wealth

Year:

1989

Language:

english

File:

PDF, 392 KB

english, 1989

53

Reaction of Amino-Acids and Peptide Bonds with Formaldehyde as Measured by Changes in the Ultra-Violet Spectra

SAIDEL, LEO. J., SATZMAN, JOEL S., ELFRING, WILLIAM H.

Journal:

Year:

1965

File:

PDF, 354 KB

1965

54

Synchronization of flexible sheets

ELFRING, GWYNN J., LAUGA, ERIC

Journal:

Journal of Fluid Mechanics

Year:

2011

Language:

english

File:

PDF, 472 KB

english, 2011

55

The efficient use of NONLIN for unbalanced multiple dose data

Gary L. Elfring, Carl M. Metzler

Journal:

Journal of Pharmacokinetics and Pharmacodynamics

Year:

1981

Language:

english

File:

PDF, 233 KB

english, 1981

56

Curve fitting and modeling in pharmacokinetics: A response

Carl M. Metzler, Gary L. Elfring

Journal:

Journal of Pharmacokinetics and Pharmacodynamics

Year:

1978

Language:

english

File:

PDF, 235 KB

english, 1978

57

Effects of colestipol hydrochloride and neomycin sulfate on cholesterol turnover in the rat

William A. Phillips, Gary L. Elfring

Journal:

Year:

1977

Language:

english

File:

PDF, 397 KB

english, 1977

58

Electromagnetic tracking for CT-guided spine interventions: phantom, ex-vivo and in-vivo results

Philipp Bruners, Tobias Penzkofer, Markus Nagel, Robert Elfring, Nina Gronloh, Thomas Schmitz-Rode, Rolf W. Günther, Andreas H. Mahnken

Journal:

European Radiology

Year:

2009

Language:

english

File:

PDF, 138 KB

english, 2009

59

Evidence Based Symptom Control in Palliative Care

Journal:

Physiotherapy (Elsevier Science)

Year:

2001

Language:

english

File:

PDF, 48 KB

english, 2001

60

RoboEarth

Waibel, M., Beetz, M., Civera, J., D'Andrea, R., Elfring, J., Galvez-Lopez, D., Haussermann, K., Janssen, R., Montiel, J.M.M., Perzylo, A., Schiessle, B., Tenorth, M., Zweigle, O., van de Molengraft,

Journal:

IEEE Robotics & Automation Magazine

Year:

2011

Language:

english

File:

PDF, 2.38 MB

english, 2011

61

Schistosoma mansoni: Rapid turnover of glycogen by adult worms in vivo

A.G.M. Tielens, A. Verwijs, R.H. Elfring, J.M. van Den Heuvel, S.G. van Den Bergh

Journal:

Experimental Parasitology

Year:

1989

Language:

english

File:

PDF, 250 KB

english, 1989

62

Pre-translational regulation by glucocorticoid of fatty acid and phosphatidylcholine synthesis in type II cells from fetal rat lung

J.J. Batenburg, R.H. Elfring

Journal:

Year:

1992

Language:

english

File:

PDF, 430 KB

english, 1992

63

165. Development and validation of the 6-min walk test as a clinical endpoint in Duchenne and Becker muscular dystrophy

C.M. McDonald, E. Henricson, J.J. Han, T. Abresch, J. Barth, A. Reha, G. Elfring, S. Peltz

Journal:

Clinical Neurophysiology

Year:

2012

Language:

english

File:

PDF, 37 KB

english, 2012

64

166. Improvements in muscle function and accidental falling in ataluren-treated patients with nonsense mutation dystrophinopathy (Duchenne/Becker muscular dystrophy)

J. Barth, C.M. McDonald, E. Henricson, T. Abresch, A. Reha, G. Elfring, S. Peltz

Journal:

Clinical Neurophysiology

Year:

2012

Language:

english

File:

PDF, 37 KB

english, 2012

65

G.P.3.05 Phase 2 study of PTC124 for nonsense mutation suppression therapy of Duchenne muscular dystrophy (DMD)

C. Bönnemann, R. Finkel, B. Wong, K. Flanigan, J. Sampson, L. Sweeney, A. Reha, G. Elfring, L. Miller, S. Hirawat

Journal:

Neuromuscular Disorders

Year:

2007

Language:

english

File:

PDF, 46 KB

english, 2007

66

T.P.1.02 The 6 min walk test (6MWT) as a clinical trial outcome measure in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

C.M. McDonald, E.K. Henricson, J.J. Han, A.R. Nicorici, R.T. Abresch, L.A. Atkinson, A.L. Reha, G.L. Elfring, L.L. Miller

Journal:

Neuromuscular Disorders

Year:

2008

Language:

english

File:

PDF, 49 KB

english, 2008

67

T.P.5.01 Phase 2b Study of PTC124 in Duchenne/Becker muscular dystrophy (DMD/BMD): Demographic and other baseline data

L.A. Atkinson, A.L. Reha, G.L. Elfring, R. Finkel, B. Wong, K. Flanigan, C.M. McDonald, K. Bushby, T. Voit, G. Spinella, V. Cwik, L. Miller

Journal:

Neuromuscular Disorders

Year:

2008

Language:

english

File:

PDF, 48 KB

english, 2008

68

T.P.3.05 Reproducibility and correlation of pretreatment outcome measures in phase 2b study of ataluren (PTC124™) in nonsense mutation Duchenne and Becker muscular dystrophy (nmDMD/BMD)

J. Florence, R.T. Abresch, M. Eagle, E. Gappmaier, A.M. Glanzman, E. Henricson, A. Reha, G.L. Elfring, L.L. Miller, L. Atkinson

Journal:

Neuromuscular Disorders

Year:

2009

Language:

english

File:

PDF, 54 KB

english, 2009

69

M.P.3.03 6-minute walk test in Duchenne muscular dystrophy: Longitudinalobservations

C. McDonald, E. Henricson, R.T. Abresch, A. Nicorici, L. Atkinson, A. Reha, G.L. Elfring, L.L. Miller

Journal:

Neuromuscular Disorders

Year:

2009

Language:

english

File:

PDF, 54 KB

english, 2009

70

M.P.3.05 Use of a novel system for grading timed function test performance in phase 2b study of ataluren (PTC124™) in nonsense mutation Duchenne and Becker muscular dystrophy (nmDMD/BMD)

M. Elfring, R.T. Abresch, J. Florence, E. Gappmaier, A.M. Glanzman, E. Henricson, A. Reha, G.L. Elfring, L.L. Miller, L. Atkinson

Journal:

Neuromuscular Disorders

Year:

2009

Language:

english

File:

PDF, 43 KB

english, 2009

71

M.P.3.04 Assessment of StepWatch™ activity monitoring in phase 2b study of ataluren (PTC124™) in nmDMD/BMD

C. McDonald, K. Coleman, E. Henricson, R.T. Abresch, M. Eagle, J. Florence, E. Gappmaier, A.M. Glanzman, A. Reha, G.L. Elfring, L.L. Miller, L. Atkinson

Journal:

Neuromuscular Disorders

Year:

2009

Language:

english

File:

PDF, 43 KB

english, 2009

72

P3.51 Results of a Phase 2b, dose-ranging study of ataluren (PTC124®) in nonsense mutation Duchenne/Becker muscular dystrophy (nmDBMD)

R. Finkel, B. Wong, K. Bushby, A. Reha, G.L. Elfring, L.L. Miller, J. Babiak, M.A. Morsy, S. Peltz, E. Welch, L. Atkinson

Journal:

Neuromuscular Disorders

Year:

2010

Language:

english

File:

PDF, 50 KB

english, 2010

73

P1.33 Disease progression observed in clinical outcome measures in placebo-treated patients with nonsense mutation dystrophinopathy

E. Mercuri, K. Bushby, C. McDonald, N. Goemans, F. Muntoni, B.T. Darras, G.L. Elfring, J. Barth, A. Reha, S.W. Peltz

Journal:

Neuromuscular Disorders

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

74

P4.10 The relationship of ataluren plasma concentration and response across clinical studies in nonsense mutation dystrophinopathy

R. Finkel, B. Wong, K. Bushby, T. Voit, M. Morsy, G.L. Elfring, J. Barth, S.W. Peltz

Journal:

Neuromuscular Disorders

Year:

2011

Language:

english

File:

PDF, 55 KB

english, 2011

75

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial

Eitan Kerem, Samit Hirawat, Shoshana Armoni, Yasmin Yaakov, David Shoseyov, Michael Cohen, Malka Nissim-Rafinia, Hannah Blau, Joseph Rivlin, Micha Aviram, Gary L Elfring, Valerie J Northcutt, Langdon

Journal:

Year:

2008

Language:

english

File:

PDF, 231 KB

english, 2008

76

Realizing innovation in services

Wietze van der Aa, Tom Elfring

Journal:

Scandinavian Journal of Management

Year:

2002

Language:

english

File:

PDF, 119 KB

english, 2002

77

51 POSTER Phase 1 single-dose safety, PK, and food-effect study of PTC299, a novel VEGF expression inhibitor for treatment of solid tumors

S. Hirawat, S. Ramael, V. Northcutt, G. Elfring, N. Parquette-Lamontagne, T. Davis, M. Weetall, N. Almstead, W. Ju, L. Miller

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 102 KB

english, 2006

78

41* PTC124 activity in CF patients carrying stop mutations: results of a phase 2 study

E. Kerem, S. Hirawat, S. Armoni, Y. Yaakov, H. Blau, J. Rivlin, M. Aviram, D. Shoseyov, M. Cohen, V. Northcutt, G. Elfring, L. Miller, M. Wilschanski

Journal:

Journal of Cystic Fibrosis

Year:

2007

Language:

english

File:

PDF, 62 KB

english, 2007

79

PTC124 treatment over 3 months improves pharmacodynamic and clinical parameters in patients with nonsense-mutation-mediated CF

M. Wilschanski, S. Armoni, Y. Yaakov, H. Blau, D. Shoseyov, M. Cohen, S. Hirawat, G.L. Elfring, A. Reha, L.L. Miller, E. Kerem

Journal:

Journal of Cystic Fibrosis

Year:

2008

Language:

english

File:

PDF, 61 KB

english, 2008

80

PTC124 induces CFTR full-length production and activity in children with nonsense-mutation-mediated CF

I. Sermet-Gaudelus, T. Leal, K. De Boeck, G. Casimir, L. Hanssens, P. Hage, D. Roussel, A. Mogenet, S. Hirawat, G.L. Elfring, S. Constantine, L.L. Miller

Journal:

Journal of Cystic Fibrosis

Year:

2008

Language:

english

File:

PDF, 61 KB

english, 2008

81

Quantitative cough assessment in cystic fibrosis (CF)

E. Kerem, M. Wilschanski, G.L. Elfring, S. Hirawat, T. Pugatsch, A. Reha, S. Constantine, S.W. Peltz, L.L. Miller

Journal:

Journal of Cystic Fibrosis

Year:

2008

Language:

english

File:

PDF, 56 KB

english, 2008

82

65 Phase 3 study of ataluren (PTC124®) in nonsense mutation cystic fibrosis (nmCF): baseline data

E. Kerem, M. Wilschanski, K. De Boeck, I. Sermet-Gaudelus, S. Constantine, G.L. Elfring, N.L. Miller, J. Barth, T. Ajayi

Journal:

Journal of Cystic Fibrosis

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

83

The stability of chymotrypsin cross-linked with formaldehyde

Leo J. Saidel, Stanley Leitzes, William H. Elfring Jr.

Journal:

Biochemical and Biophysical Research Communications

Year:

1964

Language:

english

File:

PDF, 241 KB

english, 1964

84

Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis

Eitan Kerem, Michael Wilschanski, Nilsen L. Miller, Thea Pugatsch, Tali Cohen, Hannah Blau, Joseph Rivlin, David Shoseyov, Allen Reha, Scott Constantine, Temitayo Ajayi, Samit Hirawat, Gary L. Elfring

Journal:

Journal of Cystic Fibrosis

Year:

2011

Language:

english

File:

PDF, 481 KB

english, 2011

85

In-depth disinfection of acrylic resins

Vonica B. Chau, Timothy R. Saunders, Meade Pimsler, Dan R. Elfring

Journal:

The Journal of Prosthetic Dentistry

Year:

1995

Language:

english

File:

PDF, 515 KB

english, 1995

86

Challenges in atmospheric science and climate

Serafin, Robert J., Dabberdt, Walter F., Leavitt, Peter R., Busalacchi, Antonio J., Elfring, Chris, Mengelt, Claudia

Journal:

Eos Transactions American Geophysical Union

Year:

2007

Language:

english

File:

PDF, 146 KB

english, 2007

87

Irinotecan (CPT-11) in Triplet Combinations in Patients with Advanced Non–Small-Cell Lung Cancer: A Review and Report of a Phase I/II Trial

Mark A. Socinski, Alan B. Sandler, Langdon L. Miller, Paula K. Locker, Cristy K. Hanover, Gary L. Elfring, Valerie K. Israel, Nicoletta Pirotta, Ronald B. Natale

Journal:

Clinical Lung Cancer

Year:

2001

Language:

english

File:

PDF, 292 KB

english, 2001

88

[International Studies in Entrepreneurship] Corporate Entrepreneurship and Venturing Volume 10 ||

Year:

2005

Language:

english

File:

PDF, 8.58 MB

english, 2005

89

63 The use of high resolution computerized tomography of the chest in evaluating the effect of ataluren in nonsense mutation cystic fibrosis (nmCF) lung disease

Ajayi, T., Konstan, M., Accurso, F.J., De Boeck, K., Kerem, E., Rowe, S., Sermet-Gaudelus, I., Wilschanski, M., Brody, A., Miller, N., Elfring, G., Spiegel, R., Peltz, S., Barth, J.

Journal:

Journal of Cystic Fibrosis

Year:

2013

Language:

english

File:

PDF, 68 KB

english, 2013

90

THE SERVICES.

Ajayi, T., Konstan, M., Accurso, F.J., De Boeck, K., Kerem, E., Rowe, S., Sermet-Gaudelus, I., Wilschanski, M., Brody, A., Miller, N., Elfring, G., Spiegel, R., Peltz, S., Barth, J.

Journal:

Year:

1893

Language:

english

File:

PDF, 208 KB

english, 1893

91

P.2.8 The 6-min walk test and clinical endpoints in Duchenne MD: Reliability, validity, and clinically-important differences

McDonald, C.M., Henricson, E.K., Abresch, R.T., Florence, J.M., Eagle, M., Gappmaier, E., Glanzman, A., Spiegel, R., Barth, J., Elfring, G., Reha, A., Peltz, S.W., P.T.C. Study Group,

Journal:

Neuromuscular Disorders

Year:

2013

Language:

english

File:

PDF, 48 KB

english, 2013

92

Lectures ON THE CHEMISTRY OF PATHOLOGY AND THERAPEUTICS.

McDonald, C.M., Henricson, E.K., Abresch, R.T., Florence, J.M., Eagle, M., Gappmaier, E., Glanzman, A., Spiegel, R., Barth, J., Elfring, G., Reha, A., Peltz, S.W., P.T.C. Study Group,

Journal:

Year:

1848

Language:

english

File:

PDF, 571 KB

english, 1848

93

Synchronization of Swimming Microorganisms

Elfring, Gwynn J., Lauga, Eric

Journal:

Biophysical Journal

Year:

2012

Language:

english

File:

PDF, 39 KB

english, 2012

94

S1 Development of a confirmatory phase 3, multicentre, randomized, double-blind, placebo-controlled study of ataluren in patients with nonsense mutation Duchenne muscular dystrophy

Reha, A., Spiegel, R., Elfring, G.L., Barth, J., Husain, M., Peltz, S.W.

Journal:

Neuromuscular Disorders

Year:

2014

Language:

english

File:

PDF, 55 KB

english, 2014

95

P.11.18 Design of a confirmatory phase 3, multicenter, randomized, double-blind, placebo-controlled study of ataluren in patients with nonsense mutation Duchenne muscular dystrophy

Barth, J., Reha, A., Spiegel, R., Elfring, G.L., Husain, M., Peltz, S.W.

Journal:

Neuromuscular Disorders

Year:

2013

Language:

english

File:

PDF, 50 KB

english, 2013

96

PP3.3 – 1808 Disease-related symptoms and activities of daily living: a novel survey of patients with nonsense mutation Duchenne muscular dystrophy

Reha, A, Barth, J, Elfring, GL, Spiegel, R

Journal:

European Journal of Paediatric Neurology

Year:

2013

Language:

english

File:

PDF, 61 KB

english, 2013

97

WS7.5 Interim results of the phase 3 open-label study of ataluren in nonsense mutation cystic fibrosis (nmCF)

Kerem, E., Wilschanski, M., Sermet-Gaudelus, I., De Boeck, K., Accurso, F.J., Konstan, M., Rowe, S., Miller, N., Elfring, G., Spiegel, R., Peltz, S., Barth, J., Ajayi, T.

Journal:

Journal of Cystic Fibrosis

Year:

2013

Language:

english

File:

PDF, 61 KB

english, 2013

98

P.11.19 Phase 2b, dose-ranging study of ataluren (PTC124®) innonsense mutation Duchenne muscular dystrophy – results of a post hoc analysis of change in %-predicted 6-min walk distance

McDonald, C.M., Henricson, E.K., Abresch, R.T., Elfring, G.L., Barth, J., Peltz, S.W., Reha, A.

Journal:

Neuromuscular Disorders

Year:

2013

Language:

english

File:

PDF, 50 KB

english, 2013

99

P.2.9 The 6-min walk test and other endpoints in Duchenne MD: Multi center longitudinal natural history observations over 48weeks

McDonald, C.M., Henricson, E.K., Abresch, R.T., Florence, J.M., Eagle, M., Gappmaier, E., Glanzman, A., Spiegel, R., Barth, J., Elfring, G., Reha, A., Peltz, S.

Journal:

Neuromuscular Disorders

Year:

2013

Language:

english

File:

PDF, 48 KB

english, 2013

100

P292 – 1807 Design of a Confirmatory Phase 3, multicenter, randomized, double-blind

Barth, J, Reha, A, Spiegel, R, Elfring, GL, Husain, M, Peltz, SW

Journal:

European Journal of Paediatric Neurology

Year:

2013

Language:

english

File:

PDF, 63 KB

english, 2013